Craft

Handa Pharmaceuticals

Stock Price

NT$66.9

2024-10-29

Market Capitalization

NT$9.2 B

2024-10-29

Revenue

NT$830.7 M

FY, 2024

Handa Pharmaceuticals Summary

Company Summary

Overview
Handa Pharmaceuticals (漢達生技醫藥股份有限公司, also known as Handa Bio-Pharmaceutical) is a company that manufactures and sells pharmaceutical drugs. It offers genetic and niche drugs for the treatment of multiple sclerosis, cancer, diabetes, schizophrenia, etc.
Type
Public
Status
Active
Founded
2014
HQ
TW | view all locations
Website
http://handapharma.com.tw
Cybersecurity rating
Sectors

LocationsView all

1 location detected

  • Tainan City HQ

    Taiwan

    3rd Floor, No. 23, Nanke 3rd Rd, Xinshi District

Handa Pharmaceuticals Financials

Summary Financials

Revenue (H1, 2025)
NT$939.8M
Gross profit (H1, 2025)
NT$898.9M
Net income (H1, 2025)
NT$367.4M
Cash (H1, 2025)
NT$995.5M
EBIT (H1, 2025)
NT$556.6M
Enterprise value
$8.3B

Footer menu